TANDEM DIABETES CARE INC (TNDM:NASDAQ)
$20.57 0.54 (2.696%)
Analysed TANDEM DIABETES CARE INC (TNDM:NASDAQ) News Sources
Wearable Injectors Market Report 2026 (8th Edition) Featuring Analysis of BD, Enable Injections, Insulet, Medtronic, Tandem Diabetes Care, West Pharmaceutical Services, and Ypsomed
21-04-2026
yahoo.com
3 Stocks Under $50 Walking a Fine Line
07-04-2026
yahoo.com
Assessing Tandem Diabetes Care (TNDM) Valuation After Recent Share Price Weakness
04-04-2026
yahoo.com
Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026
02-04-2026
yahoo.com
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know
27-03-2026
yahoo.com
3 Small-Cap Stocks That Concern Us
25-03-2026
yahoo.com
Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch
22-03-2026
marketbeat.com
3 Reasons to Sell TNDM and 1 Stock to Buy Instead
19-03-2026
yahoo.com
Micron downgraded, Five Below upgraded: Wall Street's top analyst calls
19-03-2026
yahoo.com
Strength Seen in Tandem Diabetes Care (TNDM): Can Its 9.1% Jump Turn into More Strength?
18-03-2026
yahoo.com
What is the current price of TANDEM DIABETES CARE INC (TNDM:NASDAQ)?
The current price of TANDEM DIABETES CARE INC (TNDM:NASDAQ) is $20.57.
TANDEM DIABETES CARE INC (TNDM:NASDAQ) absolute price change since previous trading day?
The absolute price change of TANDEM DIABETES CARE INC (TNDM:NASDAQ) since the previous trading day is $0.54.
TANDEM DIABETES CARE INC (TNDM:NASDAQ) percentage price change since previous trading day?
The percentage price change of TANDEM DIABETES CARE INC (TNDM:NASDAQ) since the previous trading day is 2.696%.
What is the most recent average sentiment score for TANDEM DIABETES CARE INC (TNDM:NASDAQ)?
The most recent average sentiment score for TANDEM DIABETES CARE INC (TNDM:NASDAQ) is 65 out of 100.
What is the most recent average sentiment for TANDEM DIABETES CARE INC (TNDM:NASDAQ)?
The most recent sentiment for TANDEM DIABETES CARE INC (TNDM:NASDAQ) is .
SEC-8K** Filing Available For TANDEM DIABETES CARE INC (TNDM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.